(19)

(11)

EP 4 475 868 A2

(12)

(88) Date of publication A3: 19.10.2023 (43) Date of publication: 18.12.2024 Bulletin 2024/51 (21) Application number: 23750271.1 (22) Date of filing: 07.02.2023

(51) International Patent Classification (IPC):  A61K 38/16(2006.01) A61P 31/14(2006.01) C07K 19/00(2006.01) A61K 47/54(2017.01) C07K 14/165(2006.01) (52) Cooperative Patent Classification (CPC): A61K 47/64; C07K 14/005; C12N 2770/20022; C12N 2770/20033; A61P 31/14; A61K 38/00; A61K 47/554; A61K 45/06; A61K 9/0043 (86) International application number: PCT/US2023/012488 (87) International publication number: WO 2023/150375 (10.08.2023 Gazette 2023/32)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 07.02.2022 US 202263307371 P 21.07.2022 US 202217870158 21.07.2022 US 202217870174 (71) Applicant: Decoy Therapeutics Inc. Cambridge, MA 02142 (US)	(72) Inventors: PENTELUTE, Bradley Revere, MA 02151 (US) HIBNER, Barbara, L. Winchester, MA 01890 (US) (74) Representative: Snaith, James Michael et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL London WC1X 8NL (GB)